You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Details for Patent: 11,833,292


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,833,292
Title:Drug delivery systems and related methods
Abstract:Systems and methods for isolating and/or desiccating a portion of a drug delivery tract of a drug delivery apparatus to reduce water vapor content therein are provided. For example, there is provided a metered dose inhaler for delivering aerosolized medicament or other matter to a user. The aerosolized medicament or other matter may be discharged from a discharge passageway within the inhaler into an inhalation passageway for inhalation by a user, and the inhaler may comprise a seal member operative to selectively isolate the discharge passageway from the inhalation passageway and external environment during inactivity. The inhaler may further comprise a desiccant material arranged to withdraw moisture from the isolated discharge passageway. In other instances, desiccant material may be arranged to withdraw moisture from the discharge passageway of the inhaler without isolating the discharge passage during inactivity.
Inventor(s):Matthew Ferriter, Denny Himel, Brian Foster, Michael L. King, Dan Deaton, Fred Hamlin, Jill Sherwood, Sarvajna Kumar Dwivedi, Robert V. Sheehy, Jr.
Assignee:Pearl Therapeutics Inc
Application Number:US16/754,585
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of U.S. Patent 11,833,292

Introduction

When analyzing a U.S. patent, it is crucial to understand the various components that define its scope and claims. This article will delve into the structure and key elements of a U.S. patent, using U.S. Patent 11,833,292 as a case study. We will explore the different sections of the patent, the significance of each, and how they collectively define the patent's scope.

Structure of a U.S. Patent

A U.S. patent is divided into several sections, each serving a specific purpose.

Document Number and Type

The document number, often prefixed with "US" and followed by a code like "B2," indicates that it is a U.S. patent with a previously published application[1].

Title and Abstract

The title provides a concise description of the invention, limited to 500 characters or less. The abstract is a brief, non-technical summary of the invention, giving an overview of its main features[1].

Background of the Invention

This section discusses the related prior art, including previously issued patents and other publications. It sets the context for the invention and explains the technical problem it solves[1].

Summary of the Invention

A brief summary outlines the main aspects of the invention, highlighting its key features and how it addresses the identified technical problem[4].

Detailed Description of the Invention

This section includes a detailed written description of the invention, accompanied by drawings that illustrate its technical details. The description must be sufficient for anyone with ordinary skill in the same technical field to understand and replicate the invention[1].

Claims

The claims section is critical as it defines the legal boundaries of the patent.

What are Claims?

Claims are paragraphs located at the end of the specification that define the scope of protection for the patent. They must include at least one claim but often include several or even hundreds of claims[1].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to an independent claim and further limit the scope of the invention[3].

Example of Claims in U.S. Patent 11,833,292

While the specific claims of U.S. Patent 11,833,292 are not provided here, an example from another patent illustrates the structure:

1. A portable electronic device, comprising:
   a first housing;
   a second housing coupled to the first housing and movable relative thereto between a closed position and an open position;
   an antenna positioned in the first housing;
   a low frequency shield coupled to the antenna and adapted to inhibit changes to the frequency response of the antenna when the portable electronic device is moved between the open position and the closed position;
   and a high frequency chassis resonator coupled to the low frequency shield and adapted to increase high frequency sensitivity of the antenna.

This example shows how claims are structured to define the invention's components and their interactions[1].

Patent Scope and Its Measurement

The scope of a patent is a crucial aspect that determines its breadth and impact.

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, including independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope, such as patent maintenance payments, forward citations, and the breadth of patent classes[3].

Impact of Narrow vs. Broad Claims

Narrower claims at publication are associated with a higher probability of grant and a shorter examination process compared to broader claims. This suggests that more focused claims can streamline the patent examination process and enhance the patent's validity[3].

Patent Landscape and Examination Process

Understanding the patent landscape and the examination process is essential for navigating the complexities of patent law.

Timeline and Costs for Patent Filings

The timeline for patent examination varies significantly by subject matter. For example, applications in the category of Computer Architecture, Software, and Information Security can take almost 21 months to receive the first office action, while Mechanical Engineering, Manufacturing, and Products can take around 30 months[4].

Restriction Requirements and Claim Amendments

Patent examiners may issue restriction requirements if the claims cover multiple independent and distinct inventions. This was illustrated in the case of Gilbert P. Hyatt, where significant claim amendments led to a restriction requirement due to the shift in the scope of the claims[2].

Legal and Policy Considerations

The legal and policy framework surrounding patents is continually evolving.

Changes in Patent Term

The Uruguay Round Agreements Act (URAA) changed the patent term from 17 years from the grant date to 20 years from the effective filing date. This change aimed to promote timely disclosure of innovations and avoid delays in patent prosecution[2].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and complexity. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes[5].

Key Takeaways

  • Patent Structure: A U.S. patent includes sections such as the title, abstract, background, summary, detailed description, drawings, and claims.
  • Claims: Claims define the legal boundaries of the patent and must be clear and specific.
  • Patent Scope: Metrics like independent claim length and count help measure patent scope, with narrower claims often leading to faster and more successful patent grants.
  • Examination Process: The timeline and costs for patent filings vary by subject matter, and restriction requirements can be issued if claims cover multiple distinct inventions.
  • Legal and Policy: Changes in patent law, such as the URAA, and proposals for a small claims patent court, continue to shape the patent landscape.

FAQs

Q: What is the purpose of the abstract in a U.S. patent? A: The abstract provides a brief, non-technical summary of the invention, giving an overview of its main features.

Q: How do claims define the scope of a patent? A: Claims define the legal boundaries of the patent by specifying the components and interactions of the invention.

Q: What are the metrics used to measure patent scope? A: Metrics include independent claim length and independent claim count, which have explanatory power for several correlates of patent scope.

Q: How has the URAA impacted patent terms? A: The URAA changed the patent term from 17 years from the grant date to 20 years from the effective filing date to promote timely disclosure of innovations.

Q: What is the proposed purpose of a small claims patent court? A: The proposed small claims patent court aims to provide a more streamlined and cost-effective way to resolve patent disputes.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. CAFC.uscourts.gov: HYATT v. PTO - United States Court of Appeals for the Federal Circuit.
  3. SSRN.com: Patent Claims and Patent Scope.
  4. SBIR.gov: TIMELINE AND COSTS FOR PATENT FILINGS - SBIR.
  5. ACUS.gov: U.S. Patent Small Claims Court.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,833,292

Showing 1 to 1 of 1 entries

International Family Members for US Patent 11,833,292

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2018347970 ⤷  Try for Free
Australia 2024205820 ⤷  Try for Free
Brazil 112020006696 ⤷  Try for Free
Canada 3078209 ⤷  Try for Free
China 111432865 ⤷  Try for Free
China 115445033 ⤷  Try for Free
Eurasian Patent Organization 039533 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.